comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Bridging the gap between GLP1-receptor outcomes: evidence for the role of | Cardiovascular Diabetology comparing cardiovascular and kidney outcomes

What This New Study Found Between Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), and Stroke Risk A new cohort study published July 2025 in JAMA Network Open followed over 60,000 adults with both type 2 diabetes and obesity

If you miss a dose, take it as soon as you remember, unless more than four days have passed

(2017) 153:448459.e8

TryShed and Yucca Health offer GLP-1-based weight loss medications as part of their programs

Calories Out Still Matters The Energy Deficit Shrinks Over Time Weight loss requires a calorie deficit burning more energy than is consumed

10.1002/jcb.29863 J Cell Biochem